DFDA

Mohs Micrographic Surgery

Treatment for Non Melanoma Skin Cancer Squamous Cell Carcinoma

Effectiveness
98%
Safety Score
75%
Clinical Trials
4
Participants
150K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
Single procedure
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$400
Side Effect Mgmt:$100
Total Annual:$3,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$30,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$3,571
Cost per Remission
$3,571
Comparison vs Surgical Excision
Cost Difference
+$1,000/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Mohs Micrographic Surgery Outcomes

for Non Melanoma Skin Cancer Squamous Cell Carcinoma

Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+98%
Common Side Effects
Pain
+30%
Swelling/Bruising
+40%
Infection
+3%
Scarring
+100%
Nerve damage (temporary/permanent)
+2%

Sources:

nih.gov
nih.gov
dntb.gov.ua

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
4 active trials recruiting for Mohs Micrographic Surgery in Non Melanoma Skin Cancer Squamous Cell Carcinoma

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT05108090RECRUITINGNA
View Study
94 participants
INTERVENTIONAL
Indianapolis, United States
Started: Oct 25, 2021

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

NCT07241585NOT YET RECRUITINGNA
View Study
54 participants
INTERVENTIONAL
Cleveland, United States
Started: Dec 1, 2025

Skin Tumor Biomarkers by Mass Spectrometry Imaging

NCT06227416ACTIVE NOT RECRUITINGNA
View Study
300 participants
INTERVENTIONAL
Copenhagen NV, Denmark
Started: Jun 15, 2020

Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma

NCT06782399NOT YET RECRUITINGEARLY_PHASE1
View Study
25 participants
INTERVENTIONAL
Started: Jul 1, 2025